These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 13798373)

  • 21. [Action of norandrostenolone phenylpropionate (N.A.P.P.) in experimental tumorization].
    VERNE J; ROTH PC
    Bull Assoc Fr Etud Cancer; 1961; 48():535-7. PubMed ID: 13925515
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on anabolic agents. I. Comparative study of the anabolic action of methandrostenolone (MA) and of 19-nortestosterone phenylpropionate (NTP) in the same individuals. II. Anabolic action of a depot form of methandrostenolone].
    de SALCEDO ; SOUSA CG
    J Med (Oporto); 1962 Apr; 47():979-82. PubMed ID: 14496307
    [No Abstract]   [Full Text] [Related]  

  • 23. [Favorable influence of 19-norandrostenolone phenylpropionate on the diabetic retinopathy].
    VALK LE
    Bull Mem Soc Fr Ophtalmol; 1959; 72():596-608. PubMed ID: 13840861
    [No Abstract]   [Full Text] [Related]  

  • 24. Muscular dystrophy treated with norethandrolone.
    DOWBEN RM; PERLSTEIN MA
    Arch Intern Med; 1961 Feb; 107():245-51. PubMed ID: 13724133
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current possibilities of treatment of progressive muscular dystrophy by the use of anabolic steroids. (Study of 18 cases)].
    DE TONI E
    Minerva Pediatr; 1960 Sep; 12():1042-67. PubMed ID: 13720901
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolonged survival of dystrophic mice treated with 17 alpha-ethyl-19-nortestosterone.
    DOWBEN RM
    Nature; 1959 Dec; 184(Suppl 25)():1966-7. PubMed ID: 13817884
    [No Abstract]   [Full Text] [Related]  

  • 27. Muscular dystrophy. IX. Body growth, muscle strength, and serum solutes during methyltestosterone-KCl therapy.
    VAN DIERMEN J; WRATNEY MJ; MATEER FM; DANOWSKI TS
    AMA J Dis Child; 1959 Apr; 97(4):439-44. PubMed ID: 13636699
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparison of the myotrophic and androgenic activities of the phenylpropionates and decanoates of testosterone and nandrolone.
    OVERBEEK GA; de VISSER
    Acta Endocrinol (Copenh); 1961 Oct; 38():285-92. PubMed ID: 14482852
    [No Abstract]   [Full Text] [Related]  

  • 29. Muscular dystrophy. X. Endocrine and electrolyte effects of methyltestosterone-KCI therapy.
    DANOWSKI TS; VAN DIERMEN J; HEINEMAN AC; MATEER FM
    AMA J Dis Child; 1959 May; 97(5, Part 1):555-60. PubMed ID: 13649085
    [No Abstract]   [Full Text] [Related]  

  • 30. [Progressive muscular dystrophy; the effect of hormone treatment].
    TASELAAR JA
    Ned Tijdschr Geneeskd; 1955 Aug; 99(34):2496-9. PubMed ID: 13265857
    [No Abstract]   [Full Text] [Related]  

  • 31. [PREVENTIVE ACTION OF NOR-ANDROSTENOLONE PHENYLPROPIONATE (N.A.P.P.) IN EXPERIMENTAL TUMORIZATION. (NEW SERIES)].
    VERNE J; ROTH PC
    Bull Assoc Fr Etud Cancer; 1964; 51():287-90. PubMed ID: 14219567
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical and biochemical effects of nandrolone phenilpropionate (durabolin) and nandrolone decanoate (deca-durabolin) in diabetic retinopathies].
    HOUTSMULLER AJ; HENKES HE
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1961; 63():57-62. PubMed ID: 14449333
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of testosterone propionate and of norandrostenolone phenylpropionate on pituitary gonadotropin content in adult rats].
    PERUZY AD; LUCHETTI L; MARINOSCI A
    Folia Endocrinol Mens Incretologia Incretoterapia; 1959 Dec; 12():808-13. PubMed ID: 14432096
    [No Abstract]   [Full Text] [Related]  

  • 34. [Research on the treatment of diseases accompanied by pathological creatinuria].
    de TONI E; REVERDITO E
    Arch Fr Pediatr; 1960; 17():705-14. PubMed ID: 13777398
    [No Abstract]   [Full Text] [Related]  

  • 35. ANABOLIC STEROIDS AND DIGITOXIN IN THE TREATMENT OF PROGRESSIVE MUSCULAR DYSTROPHY.
    HEYCK H; LAUDAHN G; LUEDERS CJ; MUELLER-STEPHANN H; SCHMIDT-PETER P
    Acta Paediatr Scand; 1965 May; 54():205-17. PubMed ID: 14313408
    [No Abstract]   [Full Text] [Related]  

  • 36. MUSCULAR DYSTROPHY. XI. TRIALS OF 1-METHYL-DELTA-1-ANDROSTENOLONE AND DIGITOXIN.
    DANOWSKI TS; SABEH G; VESTER JW; SARVER ME; SUNDER JH
    Arch Intern Med; 1965 Mar; 115():294-301. PubMed ID: 14252051
    [No Abstract]   [Full Text] [Related]  

  • 37. Methandrostenolone and nandrolone decanoate in muscular dystrophy; a controlled trial.
    BARWICK DD; NEWELL DJ; WALTON JN
    Neurology; 1963 Jan; 13():12-23. PubMed ID: 13969794
    [No Abstract]   [Full Text] [Related]  

  • 38. [Significance of the use of Durabolin on diphtheria patients].
    MINAMISAWA Y; SAITO M
    Nihon Densenbyo Gakkai Zasshi; 1962 May; 36():39-42. PubMed ID: 14474273
    [No Abstract]   [Full Text] [Related]  

  • 39. ON THE MECHANISM OF ACTION OF NANDROLONE PHENYLPROPIONATE AND NANDROLONE DECANOATE IN RATS.
    VAN DER VIES J
    Acta Endocrinol (Copenh); 1965 Jun; 49():271-82. PubMed ID: 14303256
    [No Abstract]   [Full Text] [Related]  

  • 40. [Durabolin in bone pathology].
    DREYFUS P
    Gaz Med Fr; 1961 Nov; 68():2579-81. PubMed ID: 13887846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.